Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom J Vulliamy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Blood Cells, Molecules & Diseases|June 18, 2002
Hematologically important mutations: glucose-6-phosphate dehydrogenaseErnest Beutler, Tom J Vulliamy
Methods in Molecular Medicine|October 24, 2003
Molecular diagnosis of Fanconi anemia and dyskeratosis congenitaAlex J Tipping, Tom J Vulliamy, Neil V Morgan, et al.
Haematologica|April 26, 2014
Targeted resequencing of 52 bone marrow failure genes in patients with aplastic anemia reveals an increased frequency of novel variants of unknown significance only in SLX4Laura C Collopy, Amanda J Walne, Tom J Vulliamy, et al.
British Journal of Haematology|November 20, 2002
A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndromeFausto Cossu, Tom J Vulliamy, Anna Marrone, et al.
British Journal of Haematology|August 6, 2003
Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian childrenOlugbemiro Sodeinde, Julia L Clarke, Tom J Vulliamy, et al.
Blood Cells, Molecules & Diseases|May 12, 2005
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failureTom J Vulliamy, Amanda Walne, Aroon Baskaradas, et al.
Blood|December 8, 2005
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentationTom J Vulliamy, Anna Marrone, Stuart W Knight, et al.
British Journal of Haematology|May 25, 2002
Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of IranSeyed A Mesbah-Namin, Mohammad H Sanati, Alireza Mowjoodi, et al.
Plos One|September 21, 2011
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutationsTom J Vulliamy, Michael J Kirwan, Richard Beswick, et al.
Blood Cells, Molecules & Diseases|May 10, 2003
Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcomeJulia L Clarke, Tom J Vulliamy, David Roper, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Blood Cells, Molecules & Diseases|June 18, 2002
Hematologically important mutations: glucose-6-phosphate dehydrogenaseErnest Beutler, Tom J Vulliamy
Methods in Molecular Medicine|October 24, 2003
Molecular diagnosis of Fanconi anemia and dyskeratosis congenitaAlex J Tipping, Tom J Vulliamy, Neil V Morgan, et al.
Haematologica|April 26, 2014
Targeted resequencing of 52 bone marrow failure genes in patients with aplastic anemia reveals an increased frequency of novel variants of unknown significance only in SLX4Laura C Collopy, Amanda J Walne, Tom J Vulliamy, et al.
British Journal of Haematology|November 20, 2002
A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndromeFausto Cossu, Tom J Vulliamy, Anna Marrone, et al.
British Journal of Haematology|August 6, 2003
Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian childrenOlugbemiro Sodeinde, Julia L Clarke, Tom J Vulliamy, et al.
Blood Cells, Molecules & Diseases|May 12, 2005
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failureTom J Vulliamy, Amanda Walne, Aroon Baskaradas, et al.
Blood|December 8, 2005
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentationTom J Vulliamy, Anna Marrone, Stuart W Knight, et al.
British Journal of Haematology|May 25, 2002
Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of IranSeyed A Mesbah-Namin, Mohammad H Sanati, Alireza Mowjoodi, et al.
Plos One|September 21, 2011
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutationsTom J Vulliamy, Michael J Kirwan, Richard Beswick, et al.
Blood Cells, Molecules & Diseases|May 10, 2003
Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcomeJulia L Clarke, Tom J Vulliamy, David Roper, et al.
Pageof 2